Skip to content
value.today

Metabolex, Inc.

Formerly METABOLEX INC

Total raised
$63 M
3 rounds on record
Latest round
$30 M
Sep 2013
First round on record
Mar 2008
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Metabolex, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Sep 2013$30 MNo. 3$10 to $50 million

Metabolex, Inc.: Raise no. 3, Sep 2013

Investors in this round

335 investors had bought by the notice of Nov 1, 2013: 335 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$30 M of $45 M offered; $15 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(c): may be advertised publicly; every buyer must be a verified accredited investor
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$2,281,343
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Charles A. McWherter, Ph. D. · Executive Officer
  • Harold Van Wart, Ph. D. · Executive Officer, Director
  • Sujal A. Shah · Executive Officer
  • Carl G. Goldfischer, M.D. · Director
  • Edward E. Penhoet, Ph.D. · Director
  • Hari G. Kumar, Ph.D. · Director
  • Kurt G. von Emster · Director
  • Louis G. Lange, M.D., Ph.D. · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • National Securities Corporation (CRD 7569) · New York, New YorkSold in all US states

Remarks in the notice

  • On the amounts: “The amount of the offering and the amount sold do not include the shares sold in connection with the conversion of debt in the amount of $16,900,000.”
  • On the use of proceeds: “Working capital and general corporate purposes.”

Signed by Sujal Shah, Acting Chief Financial Officer. Source: SEC Form D and 1 amendment, newest notice filed Nov 1, 2013. Read the notice at the SEC.

equity, optionsSEC
Nov 2009$6 MNo. 2$2 to $10 million

Metabolex, Inc.: Raise no. 2, Nov 2009

Investors in this round

27 investors had bought by the notice of Nov 10, 2009: 27 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $9 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Charles McWherter · Executive Officer
  • David Karpf · Executive Officer
  • Donald Hill · Executive Officer
  • Harold Van Wart · Executive Officer, Director
  • Paul Quinlan · Executive Officer
  • Anthony Evnin · Director
  • Bradley Bolzon · Director
  • Carl Goldfischer · Director
  • Daan van den Noort · Director
  • Edward Penhoet · Director
  • Kurt Von Emster · Director
  • Louis Lange · Director
  • Robert Zerbe · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Paul Quinlan, Secretary. Source: SEC Form D, newest notice filed Nov 10, 2009. Read the notice at the SEC.

equity, debt, optionsSEC
Mar 2008$28 MNo. 1$10 to $50 million

Metabolex, Inc.: Raise no. 1, Mar 2008

Investors in this round

1 investor had bought by the notice of Jul 21, 2009: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$28 M of $28 M offered
Smallest investment taken
$1
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Charles McWherter · Executive Officer
  • David Karpf · Executive Officer
  • Donald Hill · Executive Officer
  • Harold Van Wart · Executive Officer, Director
  • Paul Quinlan · Executive Officer
  • Anthony Evnin · Director
  • Bradley Bolzon · Director
  • Carl Goldfischer · Director
  • Daan van den Noort · Director
  • Edward Penhoet · Director
  • Kurt Von Emster · Director
  • Louis Lange · Director
  • Robert Zerbe · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Paul Quinlan, Secretary. Source: SEC Form D, newest notice filed Jul 21, 2009. Read the notice at the SEC.

debt, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Metabolex, Inc. chose not to state its revenue in its newest notice of a funding round (Nov 2013).

    SEC Form D · Nov 2013

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Nov 2013

That is all the official record says: Metabolex, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: the address on record now leads to another company's site.

Investors#

No investor of Metabolex, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 335 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Metabolex, Inc.
NameRoleNamed in
Charles A. McWherter, Ph. D.Executive officerNov 2013
Harold Van Wart, Ph. D.Executive officerNov 2013
Sujal A. ShahExecutive officerNov 2013
Charles McWherterExecutive officerNov 2009
David KarpfExecutive officerNov 2009
Donald HillExecutive officerNov 2009
Harold Van WartExecutive officerNov 2009
Paul QuinlanExecutive officerNov 2009
Carl G. Goldfischer, M.D.DirectorNov 2013
Edward E. Penhoet, Ph.D.DirectorNov 2013
Hari G. Kumar, Ph.D.DirectorNov 2013
Harold Van Wart, Ph. D.DirectorNov 2013
Kurt G. von EmsterDirectorNov 2013
Louis G. Lange, M.D., Ph.D.DirectorNov 2013
Anthony EvninDirectorNov 2009
Bradley BolzonDirectorNov 2009
Carl GoldfischerDirectorNov 2009
Daan van den NoortDirectorNov 2009
Edward PenhoetDirectorNov 2009
Harold Van WartDirectorNov 2009
Kurt Von EmsterDirectorNov 2009
Louis LangeDirectorNov 2009
Robert ZerbeDirectorNov 2009

About

Company in Newark, United States.